This is a critically important topic to convey clearly: stopping weightloss injections often leads to relapse or regain of body weight, especially if lifestyle changes have not become deeply established and support is not maintained
Krajewski PK, Matusiak , Szepietowski JC
[DOI] [PubMed] [Google Scholar] Yang P, Knight WC, Li H, Guo Y, Perlmutter JS, Benzinger TLS, Morris JC, Xu J (2021) Dopamine D1 + D3 receptor density may correlate with Parkinson disease clinical features
Weight loss drugs targeting the hypothalamus often converge on the leptinmelanocortin pathway
The article's comparison table gives berberine alone a typical A1C reduction of 0.5 to 1.5 percent, citing small monotherapy studies over 12 weeks, and gives a GLP-1 agonist alone 1 to 2 percent